Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrating Long-Acting Injectable Treatment to Improve Medication Adherence Among Persons Living With HIV and Opioid Use Disorder

NCT05991622 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.

NCT NCT05991622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05991622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrating Long-Acting Injectable Treatment to Improve Medication Adherence Among Persons Living With HIV and Opioid Use Disorder
Lead sponsor
Rhode Island Hospital
Phase
Phase 2
Overall status
Withdrawn
Start date
April 1, 2022
Completion date
February 13, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus, opioid use disorder